DEFA14A: AtriCure Defends Officer Exculpation Proposal Against Glass Lewis Recommendation
Supplemental Proxy Material
AtriCure urges stockholders to approve a proposal to amend its certificate of incorporation to limit officer liability, countering a recommendation from Glass Lewis.
Summary
- AtriCure has issued a letter to stockholders addressing a recommendation from Glass Lewis (GL) to vote against the company's proposal to amend its Second Amended and Restated Certificate of Incorporation to include officer exculpation.
- The company argues that the proposal aligns with Delaware law and is necessary to attract and retain quality officers.
- AtriCure contends that the proposal is a balanced approach to officer accountability, protecting them from frivolous lawsuits while preserving stockholders' rights.
- The company highlights that Institutional Shareholder Services (ISS) recommends voting in favor of the Officer Exculpation Proposal.
- The proposed amendment would not protect officers from liability for disloyalty or bad faith, and stockholders can still bring claims for breach of fiduciary duty of loyalty or actions taken in bad faith.
- AtriCure believes that officer exculpation will reduce litigation costs, insurance premiums, and distractions, ultimately benefiting stockholders.
- The company notes that many public companies have proposed similar amendments to limit officer liability.
Sentiment
Score: 7
Explanation: The document presents a balanced argument, defending a proposal that has received mixed reactions. While there are potential benefits to the proposal, there are also risks and concerns. The overall tone is persuasive and confident.
Positives
- The proposal aligns AtriCure with Delaware law, potentially making the company more attractive to talented executives.
- Officer exculpation could reduce litigation costs and insurance premiums, freeing up cash for the core business.
- The proposal encourages officers to pursue value-creating transactions without fear of personal liability.
- ISS recommends voting for the proposal, lending credibility to AtriCure's position.
Negatives
- Glass Lewis recommends voting against the proposal, raising concerns about officer accountability.
- The proposal could be perceived as reducing officer accountability, potentially leading to less oversight.
- The increasingly litigious environment facing officers of U.S. public companies and the SEC rules applicable to officers are headwinds for recruiting.
Risks
- Failure to approve the proposal could put AtriCure at a disadvantage to its peers who provide officer exculpation.
- Increased duty of care litigation could make officers more risk-averse, potentially harming the business.
- Frivolous litigation could continue to increase D&O insurance premiums and distract from core business activities.
Future Outlook
AtriCure believes that exculpation of officers will eventually become standard among Delaware corporations.
Management Comments
- We agree that officers should be accountable to stockholders and held to high standards of conduct.
- Exposing our officers to second-guessing by the plaintiffs bar does little to promote accountability while resulting in significant costs.
- Our Board wants officers of AtriCure to pursue value-creating transactions without fear of personal liability.
- Our Board believes that providing for the exculpation of officers will enhance AtriCure's ability to attract and retain quality officers.
Industry Context
Many public companies are seeking to exculpate officers from duty of care claims, following the Delaware legislature's amendment to the Delaware General Corporation Law.
Comparison to Industry Standards
- The document mentions that several hundred public companies have proposed amendments to their certificates of incorporation to limit officer liability.
- The exculpation of directors has been standard among Delaware corporations since the 1980s.
Stakeholder Impact
- Approval of the proposal could impact stockholders by reducing litigation costs and insurance premiums.
- The proposal could impact officers by providing them with greater protection from liability.
- Failure to approve the proposal could impact AtriCure's ability to attract and retain quality officers.
Next Steps
- Stockholders are encouraged to vote on Proposal No. 5, the Officer Exculpation Proposal.
- Stockholders who have already voted can revoke their proxy and change their vote before the Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| April 3, 2024 | AtriCure filed a definitive proxy statement with the SEC. |
| April 17, 2024 | Glass Lewis published its proxy paper. |
| April 23, 2024 | AtriCure issued a letter to its stockholders. |
| May 13, 2024 | AtriCure's Annual Meeting of Stockholders is scheduled. |
Keywords
Officer Exculpation, Proxy Statement, Delaware Law, Liability, Stockholders, AtriCure, Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.